Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

a study on Cancer, General Fertility Preservation

Summary

Eligibility
for people ages 0-50 (full criteria)
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by H. Irene Su, MD, MSCE (ucsd)

Description

Summary

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with observing and gathering information on how the intervention is implemented. The investigators hypothesize that implementation of the intervention will result in increased young cancer survivors' engagement in goal-concordant oncofertility care.

Official Title

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients: a Stepped Wedge Cluster Randomized Controlled Trial

Keywords

Cancer, Fertility Preservation, Oncofertility, Adolescent and young adult cancer, Multi-component oncofertility care intervention

Eligibility

You can join if…

Open to people ages 0-50

  • Newly diagnosed cancer or cancer relapse
  • Primary language English or Spanish
  • Receiving oncology care at participating clinical sites
  • Ages 0 to 42 years if female
  • Ages 0 to 50 years if male

You CAN'T join if...

  • Non-melanoma skin cancer, because primary treatment is excision with no infertility risk
  • Metastatic/Stage IV non-thyroid solid tumors, because of poor prognosis

Locations

  • University of California San Diego accepting new patients
    La Jolla California 92093 United States
  • Rady Children's Hospital San Diego accepting new patients
    San Diego California 92123 United States
  • City of Hope accepting new patients
    Duarte California 91010-3000 United States
  • Cancer Resource Center of the Desert in progress, not accepting new patients
    El Centro California 92243 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT05443737
Phase
Phase 3 research study
Study Type
Interventional
Participants
Expecting 2800 study participants
Last Updated